Back to ALLO
GOLDMAN SACHS GROUP INC → ALLO
GOLDMAN SACHS GROUP INC ALLO Position History
Allogene Therapeutics, Inc. • Healthcare
Quarters held
14
Latest value
$322K
Q2 2026
Peak value
$12.5M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $6.1M |
| Q2 2025 | $134K |
| Q3 2025 | $1.3M |
| Q3 2025 | $152K |
| Q4 2025 | $45K |
| Q4 2025 | $1.7M |
| Q4 2025 | $1.4M |
| Q4 2025 | $1.4M |
| Q4 2025 | $1.7M |
| Q4 2025 | $45K |
| Q1 2026 | $5.9M |
| Q1 2026 | $862K |
| Q2 2026 | $12.5M |
| Q2 2026 | $322K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $322K | 155.0K | — | — |
| Q2 2026 | $12.5M | 5.99M | — | — |
| Q1 2026 | $862K | 353.4K | — | — |
| Q1 2026 | $5.9M | 2.41M | — | — |
| Q4 2025 | $45K | 33.1K | — | — |
| Q4 2025 | $1.7M | 1.22M | — | — |
| Q4 2025 | $1.4M | 1.04M | — | — |
| Q4 2025 | $1.4M | 1.04M | — | — |
| Q4 2025 | $1.7M | 1.22M | — | — |
| Q4 2025 | $45K | 33.1K | — | — |
| Q3 2025 | $152K | 122.6K | — | — |
| Q3 2025 | $1.3M | 1.08M | — | — |
| Q2 2025 | $134K | 118.2K | — | — |
| Q2 2025 | $6.1M | 5.38M | — | — |